In Phase A, contributors will receive diverse doses and schedules of oral ABBV-744 pill to discover Secure dosing regimen. Additional members will probably be enrolled for the recognized monotherapy dosign routine. In Phase B, contributors will acquire oral ruxolitinib and ABBV-744 is going to be provided as "include-on" therapy. In https://abbv-744-brd4-inhibition70146.blogspothub.com/31231588/little-known-facts-about-abbv-744-as-a-potential-therapeutic-option-for-aggressive-cancers